Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
33,24 SEK | +3,55% | -4,26% | -15,05% |
20/12 | Redeye alza il fair value di Hansa Biopharma dopo i risultati positivi dello studio per la GBS | FW |
18/12 | Hansa Biopharma AB - Special Call |
Aggiungi a un elenco 0 selezionato | Fatturato | Margine netto | Margine Operativo | ROE | ROA | Leva (indebitamento/EBITDA) | |
---|---|---|---|---|---|---|---|
12 033 436,68 | -620.25% | -588.02% | -382.37x | - | -0.18x | ||
7 371 112 525,51 | +9.74% | +13.98% | 6.52x | 3.82x | 0.46x | ||
14 984 000 000,00 | +9.06% | +20.36% | 32.01x | 5.22x | 3.45x | ||
1 493 591 731,98 | +24.61% | +29.93% | 5.07x | 4.31x | 1.46x | ||
8 120 176 000,00 | +7.54% | +19.31% | 6.9x | 3.58x | 2x | ||
2 327 500 000,00 | +42.31% | +50.91% | 18.27x | 14.91x | -1.85x | ||
6 848 000 000,00 | -68.84% | -61.90% | -28.59x | -21.29x | 2.38x | ||
1 159 060 000,00 | +14.50% | +31.94% | 14.11x | 6.29x | 0.4x | ||
1 885 842 000,00 | +15.00% | +17.94% | 59.83x | 18.8x | -0.29x | ||
1 965 311 000,00 | +17.37% | +26.90% | 4.69x | 2.75x | 0.69x | ||
4 129 409 000,00 | +11.49% | +20.31% | 16.7x | 6.95x | 2.34x | ||
11 580 000,00 | -3,768.28% | -4,207.12% | -34.76x | -30.38x | 3.85x | ||
249 380 000,00 | -203.30% | -194.99% | -157.13x | - | 0.99x | ||
1 573 627 746,48 | +13.88% | +14.92% | 13.86x | 6.82x | 1.36x | ||
1 007 083 782,27 | +27.44% | +35.35% | 9.95x | 7.09x | -1.51x | ||
531 822 000,00 | -40.26% | - | - | - | - | ||
788 000 000,00 | -46.45% | -44.80% | -76.34x | -13.26x | 3.21x | ||
312 568 105,49 | +1.04% | +10.29% | 34.35x | 12.03x | -1.95x | ||
1 663 405 000,00 | +21.39% | +24.90% | 21.69x | 11.88x | -1.07x | ||
Media | 2.970.184.333,07 | -238,53% | -265,54% | -24,18x | 2,47x | 0,88x | |
Media ponderata per Capi. | 5.355.577.418,87 | -114,61% | -122,67% | 5,38x | 3,36x | 1,20x |
- Borsa valori
- Azioni
- Azione HNSA
- Settore Hansa Biopharma AB
- Confronti finanziari
MarketScreener is also available in this country: United States.
Switch edition